CareRx (CRRX) Ratios

81 Followers

CareRx Ratios

TSE:CRRX's free cash flow for Q4 2025 was C$0.26. For the 2025 fiscal year, TSE:CRRX's free cash flow was decreased by C$ and operating cash flow was C$0.03. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	1.06	1.06	0.99	1.05	1.40
Quick Ratio	0.78	0.78	0.71	0.73	1.08
Cash Ratio	0.23	0.23	0.14	0.11	0.44
Solvency Ratio	0.31	0.31	0.11	0.10	-0.07
Operating Cash Flow Ratio	0.46	0.44	0.60	0.44	0.35
Short-Term Operating Cash Flow Coverage	3.72	3.50	7.13	2.76	3.01
Net Current Asset Value	C$ -76.50M	C$ -76.50M	C$ -76.97M	C$ -84.95M	C$ -110.90M
Leverage Ratios
Debt-to-Assets Ratio	0.31	0.31	0.37	0.42	0.51
Debt-to-Equity Ratio	0.71	0.71	0.98	1.20	2.10
Debt-to-Capital Ratio	0.42	0.42	0.50	0.55	0.68
Long-Term Debt-to-Capital Ratio	0.25	0.25	0.32	0.41	0.61
Financial Leverage Ratio	2.31	2.31	2.65	2.84	4.10
Debt Service Coverage Ratio	3.51	3.60	1.64	1.19	0.04
Interest Coverage Ratio	1.56	1.74	0.49	0.33	-1.44
Debt to Market Cap	0.19	0.18	0.36	0.73	0.88
Interest Debt Per Share	1.35	1.35	1.52	1.96	3.16
Net Debt to EBITDA	2.20	2.10	3.08	3.68	-175.17
Profitability Margins
Gross Profit Margin	27.53%	25.02%	29.47%	22.85%	28.80%
EBIT Margin	2.86%	3.21%	1.29%	1.26%	-5.42%
EBITDA Margin	7.81%	8.16%	6.52%	6.65%	-0.16%
Operating Profit Margin	2.88%	3.21%	1.23%	1.26%	-5.75%
Pretax Profit Margin	0.91%	0.91%	-1.22%	-2.59%	-9.40%
Net Profit Margin	7.06%	7.06%	-1.23%	-1.46%	-9.00%
Continuous Operations Profit Margin	7.06%	7.06%	-1.23%	-1.46%	-9.00%
Net Income Per EBT	779.21%	779.21%	100.72%	56.33%	95.70%
EBT Per EBIT	31.46%	28.22%	-98.76%	-205.46%	163.58%
Return on Assets (ROA)	10.33%	10.33%	-2.01%	-2.33%	-12.99%
Return on Equity (ROE)	28.24%	23.86%	-5.34%	-6.63%	-53.30%
Return on Capital Employed (ROCE)	5.61%	6.25%	2.82%	2.76%	-10.94%
Return on Invested Capital (ROIC)	5.39%	6.01%	2.68%	1.44%	-9.97%
Return on Tangible Assets	16.95%	16.95%	-3.78%	-4.60%	-24.27%
Earnings Yield	11.50%	10.90%	-3.63%	-5.85%	-28.19%
Efficiency Ratios
Receivables Turnover	11.25	11.25	11.06	10.27	10.24
Payables Turnover	7.92	8.19	8.13	9.83	8.92
Inventory Turnover	15.29	15.82	14.64	14.55	13.39
Fixed Asset Turnover	6.82	6.82	6.45	7.11	7.29
Asset Turnover	1.46	1.46	1.64	1.60	1.44
Working Capital Turnover Ratio	60.96	210.66	293.72	26.24	11.30
Cash Conversion Cycle	10.20	10.94	13.01	23.47	21.96
Days of Sales Outstanding	32.44	32.44	32.99	35.53	35.63
Days of Inventory Outstanding	23.87	23.07	24.94	25.08	27.27
Days of Payables Outstanding	46.11	44.56	44.92	37.15	40.93
Operating Cycle	56.30	55.50	57.93	60.61	62.89
Cash Flow Ratios
Operating Cash Flow Per Share	0.47	0.44	0.63	0.48	0.47
Free Cash Flow Per Share	0.37	0.35	0.50	0.33	0.18
CapEx Per Share	0.10	0.09	0.13	0.15	0.29
Free Cash Flow to Operating Cash Flow	0.79	0.80	0.79	0.68	0.39
Dividend Paid and CapEx Coverage Ratio	4.72	3.40	4.68	3.15	1.64
Capital Expenditure Coverage Ratio	4.72	4.93	4.68	3.15	1.64
Operating Cash Flow Coverage Ratio	0.38	0.35	0.46	0.28	0.17
Operating Cash Flow to Sales Ratio	0.08	0.07	0.10	0.07	0.06
Free Cash Flow Yield	10.17%	9.16%	24.07%	20.23%	7.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	8.66	9.17	-27.58	-17.08	-3.55
Price-to-Sales (P/S) Ratio	0.61	0.65	0.34	0.25	0.32
Price-to-Book (P/B) Ratio	2.07	2.19	1.47	1.13	1.89
Price-to-Free Cash Flow (P/FCF) Ratio	9.79	10.92	4.15	4.94	13.97
Price-to-Operating Cash Flow Ratio	7.74	8.70	3.27	3.37	5.46
Price-to-Earnings Growth (PEG) Ratio	<0.01	-0.01	1.33	0.20	-0.33
Price-to-Fair Value	2.07	2.19	1.47	1.13	1.89
Enterprise Value Multiple	10.00	10.03	8.27	7.43	-374.92
Enterprise Value	290.30M	303.17M	197.67M	183.17M	228.70M
EV to EBITDA	10.04	10.03	8.27	7.43	-374.92
EV to Sales	0.78	0.82	0.54	0.49	0.60
EV to Free Cash Flow	12.59	13.81	6.62	9.81	26.23
EV to Operating Cash Flow	9.92	11.01	5.20	6.69	10.24
Tangible Book Value Per Share	0.17	0.17	-0.33	-0.57	-1.23
Shareholders’ Equity Per Share	1.74	1.75	1.40	1.42	1.35
Tax and Other Ratios
Effective Tax Rate	-6.79	-6.79	>-0.01	0.44	0.04
Revenue Per Share	5.89	5.90	6.09	6.46	8.02
Net Income Per Share	0.42	0.42	-0.07	-0.09	-0.72
Tax Burden	7.79	7.79	1.01	0.56	0.96
Interest Burden	0.32	0.28	-0.95	-2.05	1.74
Research & Development to Revenue	0.00	0.00	0.00	0.00	0.00
SG&A to Revenue	0.16	0.22	0.09	0.08	0.27
Stock-Based Compensation to Revenue	<0.01	0.00	<0.01	<0.01	0.01
Income Quality	1.12	1.05	-8.44	-5.06	-0.65

Currency in CAD